nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—SLC22A1—Estropipate—osteoporosis	0.234	0.528	CbGbCtD
Amiloride—SLC22A2—Estradiol—osteoporosis	0.112	0.252	CbGbCtD
Amiloride—SLC22A1—Estradiol—osteoporosis	0.0971	0.219	CbGbCtD
Amiloride—PLAU—Dissolution of Fibrin Clot—ANXA2—osteoporosis	0.0116	0.0453	CbGpPWpGaD
Amiloride—SLC9A1—Osteoclast Signaling—ACP5—osteoporosis	0.00928	0.0361	CbGpPWpGaD
Amiloride—SLC9A1—Osteoclast Signaling—TNFSF11—osteoporosis	0.00827	0.0322	CbGpPWpGaD
Amiloride—SLC9A1—Osteoclast Signaling—TNFRSF11B—osteoporosis	0.00769	0.0299	CbGpPWpGaD
Amiloride—SLC9A1—Osteoclast Signaling—CTSK—osteoporosis	0.00769	0.0299	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—GSN—osteoporosis	0.00711	0.0277	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—IBSP—osteoporosis	0.00679	0.0265	CbGpPWpGaD
Amiloride—AOC1—Tryptophan metabolism—CYP19A1—osteoporosis	0.00507	0.0197	CbGpPWpGaD
Amiloride—PLAU—Blood Clotting Cascade—FGA—osteoporosis	0.00492	0.0191	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—TLN1—osteoporosis	0.00487	0.019	CbGpPWpGaD
Amiloride—PLAU—Blood Clotting Cascade—FGB—osteoporosis	0.00447	0.0174	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—PTH1R—osteoporosis	0.00447	0.0174	CbGpPWpGaD
Amiloride—PLAU—Osteopontin Signaling—SPP1—osteoporosis	0.00422	0.0164	CbGpPWpGaD
Amiloride—SLC9A1—RhoA signaling pathway—TLN1—osteoporosis	0.00411	0.016	CbGpPWpGaD
Amiloride—SLC9A1—RhoA signaling pathway—VCL—osteoporosis	0.00406	0.0158	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—RAP1A—osteoporosis	0.00402	0.0156	CbGpPWpGaD
Amiloride—SLC9A1—Osteoclast Signaling—SPP1—osteoporosis	0.00396	0.0154	CbGpPWpGaD
Amiloride—PLAU—Beta2 integrin cell surface interactions—FGA—osteoporosis	0.00394	0.0153	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—COL1A2—osteoporosis	0.00367	0.0143	CbGpPWpGaD
Amiloride—PLAU—Beta2 integrin cell surface interactions—FGB—osteoporosis	0.00359	0.014	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NFATC1—osteoporosis	0.00349	0.0136	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway—LRP5—osteoporosis	0.00334	0.013	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—COL1A2—osteoporosis	0.00326	0.0127	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway—LRP6—osteoporosis	0.0032	0.0124	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—BGLAP—osteoporosis	0.00318	0.0124	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FGA—osteoporosis	0.00293	0.0114	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—FGA—osteoporosis	0.00288	0.0112	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—GSN—osteoporosis	0.00268	0.0104	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FGB—osteoporosis	0.00267	0.0104	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—COL1A2—osteoporosis	0.00266	0.0104	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—FGB—osteoporosis	0.00262	0.0102	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—COL1A1—osteoporosis	0.0025	0.00974	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—LRP5—osteoporosis	0.00239	0.00929	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—BGLAP—osteoporosis	0.00235	0.00915	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—PTH—osteoporosis	0.00235	0.00914	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—COL1A2—osteoporosis	0.00231	0.009	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—LRP6—osteoporosis	0.00228	0.00889	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—GSN—osteoporosis	0.00225	0.00875	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—ALPL—osteoporosis	0.00222	0.00863	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—COL1A2—osteoporosis	0.00221	0.00859	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—AGER—osteoporosis	0.00213	0.00829	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—SPP1—osteoporosis	0.00211	0.0082	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—NFATC1—osteoporosis	0.0021	0.00816	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway—WNT1—osteoporosis	0.00207	0.00807	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—FGA—osteoporosis	0.00204	0.00795	CbGpPWpGaD
Amiloride—PLAU—Complement and Coagulation Cascades—FGB—osteoporosis	0.00203	0.00791	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—PTHLH—osteoporosis	0.00195	0.00757	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—FGB—osteoporosis	0.00186	0.00723	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—PKM—osteoporosis	0.00179	0.00697	CbGpPWpGaD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoporosis	0.00179	0.00697	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—KL—osteoporosis	0.00178	0.00694	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—COL1A1—osteoporosis	0.00178	0.00692	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—PGLS—osteoporosis	0.0017	0.00661	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—SPP1—osteoporosis	0.00162	0.00631	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—VCL—osteoporosis	0.00156	0.00606	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—ACTG1—osteoporosis	0.00156	0.00606	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—WNT1—osteoporosis	0.00148	0.00577	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—WNT1—osteoporosis	0.00141	0.00547	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—ADCY5—osteoporosis	0.00137	0.00533	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—SPP1—osteoporosis	0.00135	0.00526	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—BMP2—osteoporosis	0.00131	0.0051	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—COL1A1—osteoporosis	0.00123	0.00477	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.00119	0.00465	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—SPP1—osteoporosis	0.00118	0.00459	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—SPP1—osteoporosis	0.00115	0.00448	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—WDR1—osteoporosis	0.00108	0.00421	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—ESR1—osteoporosis	0.00106	0.00414	CbGpPWpGaD
Amiloride—SLC9A1—G Protein Signaling Pathways—ADCY5—osteoporosis	0.001	0.0039	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—TPI1—osteoporosis	0.00093	0.00362	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—ESR1—osteoporosis	0.000927	0.00361	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000904	0.00352	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000904	0.00352	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000904	0.00352	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000904	0.00352	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000904	0.00352	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—IGF1—osteoporosis	0.000862	0.00336	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—GAPDH—osteoporosis	0.000858	0.00334	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—CAP1—osteoporosis	0.000855	0.00333	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—TNF—osteoporosis	0.00084	0.00327	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—SOD2—osteoporosis	0.000831	0.00324	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—osteoporosis	0.000724	0.00282	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MGLL—osteoporosis	0.000679	0.00264	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—IL6—osteoporosis	0.000678	0.00264	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—ENO1—osteoporosis	0.000676	0.00263	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ANXA2—osteoporosis	0.000621	0.00242	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PLEK—osteoporosis	0.000621	0.00242	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000608	0.00203	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—IRS1—osteoporosis	0.000608	0.00237	CbGpPWpGaD
Amiloride—Somnolence—Calcitriol—osteoporosis	0.000607	0.00202	CcSEcCtD
Amiloride—Decreased appetite—Ibandronate—osteoporosis	0.000606	0.00202	CcSEcCtD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—osteoporosis	0.000604	0.00235	CbGpPWpGaD
Amiloride—Pain—Raloxifene—osteoporosis	0.000602	0.00201	CcSEcCtD
Amiloride—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000602	0.00201	CcSEcCtD
Amiloride—Depression—Estradiol—osteoporosis	0.000601	0.002	CcSEcCtD
Amiloride—Fatigue—Ibandronate—osteoporosis	0.000601	0.002	CcSEcCtD
Amiloride—Chest pain—Risedronate—osteoporosis	0.0006	0.002	CcSEcCtD
Amiloride—Arthralgia—Risedronate—osteoporosis	0.0006	0.002	CcSEcCtD
Amiloride—Alopecia—Conjugated Estrogens—osteoporosis	0.000598	0.00199	CcSEcCtD
Amiloride—Constipation—Ibandronate—osteoporosis	0.000596	0.00199	CcSEcCtD
Amiloride—Pain—Ibandronate—osteoporosis	0.000596	0.00199	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000596	0.00232	CbGpPWpGaD
Amiloride—Pruritus—Etidronic acid—osteoporosis	0.000595	0.00198	CcSEcCtD
Amiloride—Gastrointestinal pain—Estropipate—osteoporosis	0.000595	0.00198	CcSEcCtD
Amiloride—Decreased appetite—Calcitriol—osteoporosis	0.000593	0.00198	CcSEcCtD
Amiloride—Back pain—Zoledronate—osteoporosis	0.000592	0.00197	CcSEcCtD
Amiloride—Feeling abnormal—Alendronate—osteoporosis	0.00059	0.00197	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL6R—osteoporosis	0.000588	0.00229	CbGpPWpGaD
Amiloride—Muscle spasms—Zoledronate—osteoporosis	0.000588	0.00196	CcSEcCtD
Amiloride—Jaundice—Estradiol—osteoporosis	0.000588	0.00196	CcSEcCtD
Amiloride—Gastrointestinal pain—Alendronate—osteoporosis	0.000586	0.00195	CcSEcCtD
Amiloride—Cough—Pamidronate—osteoporosis	0.000584	0.00195	CcSEcCtD
Amiloride—Constipation—Calcitriol—osteoporosis	0.000584	0.00194	CcSEcCtD
Amiloride—Pain—Calcitriol—osteoporosis	0.000584	0.00194	CcSEcCtD
Amiloride—Flatulence—Conjugated Estrogens—osteoporosis	0.00058	0.00193	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IGF1—osteoporosis	0.00058	0.00226	CbGpPWpGaD
Amiloride—Tension—Conjugated Estrogens—osteoporosis	0.000578	0.00192	CcSEcCtD
Amiloride—Gastrointestinal pain—Raloxifene—osteoporosis	0.000576	0.00192	CcSEcCtD
Amiloride—Diarrhoea—Etidronic acid—osteoporosis	0.000575	0.00192	CcSEcCtD
Amiloride—Abdominal pain—Estropipate—osteoporosis	0.000575	0.00191	CcSEcCtD
Amiloride—Feeling abnormal—Ibandronate—osteoporosis	0.000575	0.00191	CcSEcCtD
Amiloride—Tremor—Zoledronate—osteoporosis	0.000573	0.00191	CcSEcCtD
Amiloride—Nervousness—Conjugated Estrogens—osteoporosis	0.000572	0.0019	CcSEcCtD
Amiloride—Gastrointestinal pain—Ibandronate—osteoporosis	0.00057	0.0019	CcSEcCtD
Amiloride—Arthralgia—Pamidronate—osteoporosis	0.00057	0.0019	CcSEcCtD
Amiloride—Back pain—Conjugated Estrogens—osteoporosis	0.00057	0.0019	CcSEcCtD
Amiloride—Abdominal pain—Alendronate—osteoporosis	0.000566	0.00189	CcSEcCtD
Amiloride—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000566	0.00189	CcSEcCtD
Amiloride—Shock—Risedronate—osteoporosis	0.000565	0.00188	CcSEcCtD
Amiloride—Gastrointestinal pain—Calcitriol—osteoporosis	0.000558	0.00186	CcSEcCtD
Amiloride—Abdominal pain—Raloxifene—osteoporosis	0.000557	0.00185	CcSEcCtD
Amiloride—Abdominal pain—Ibandronate—osteoporosis	0.000551	0.00184	CcSEcCtD
Amiloride—Confusional state—Pamidronate—osteoporosis	0.000551	0.00183	CcSEcCtD
Amiloride—Vertigo—Zoledronate—osteoporosis	0.000549	0.00183	CcSEcCtD
Amiloride—Haemoglobin—Estradiol—osteoporosis	0.000544	0.00181	CcSEcCtD
Amiloride—Haemorrhage—Estradiol—osteoporosis	0.000541	0.0018	CcSEcCtD
Amiloride—Palpitations—Zoledronate—osteoporosis	0.00054	0.0018	CcSEcCtD
Amiloride—Abdominal pain—Calcitriol—osteoporosis	0.00054	0.0018	CcSEcCtD
Amiloride—Shock—Pamidronate—osteoporosis	0.000538	0.00179	CcSEcCtD
Amiloride—PLAU—Hemostasis—TLN1—osteoporosis	0.000535	0.00208	CbGpPWpGaD
Amiloride—Vomiting—Etidronic acid—osteoporosis	0.000535	0.00178	CcSEcCtD
Amiloride—Cough—Zoledronate—osteoporosis	0.000534	0.00178	CcSEcCtD
Amiloride—Rash—Etidronic acid—osteoporosis	0.00053	0.00177	CcSEcCtD
Amiloride—Dermatitis—Etidronic acid—osteoporosis	0.00053	0.00176	CcSEcCtD
Amiloride—Vertigo—Conjugated Estrogens—osteoporosis	0.000529	0.00176	CcSEcCtD
Amiloride—PLAU—Hemostasis—VCL—osteoporosis	0.000528	0.00206	CbGpPWpGaD
Amiloride—Headache—Etidronic acid—osteoporosis	0.000527	0.00175	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000524	0.00174	CcSEcCtD
Amiloride—Asthenia—Estropipate—osteoporosis	0.000522	0.00174	CcSEcCtD
Amiloride—Visual impairment—Estradiol—osteoporosis	0.000522	0.00174	CcSEcCtD
Amiloride—Anorexia—Pamidronate—osteoporosis	0.000521	0.00173	CcSEcCtD
Amiloride—Arthralgia—Zoledronate—osteoporosis	0.000521	0.00173	CcSEcCtD
Amiloride—Chest pain—Zoledronate—osteoporosis	0.000521	0.00173	CcSEcCtD
Amiloride—Palpitations—Conjugated Estrogens—osteoporosis	0.00052	0.00173	CcSEcCtD
Amiloride—Insomnia—Risedronate—osteoporosis	0.00052	0.00173	CcSEcCtD
Amiloride—PLAU—Endochondral Ossification—TGFB1—osteoporosis	0.000517	0.00201	CbGpPWpGaD
Amiloride—Paraesthesia—Risedronate—osteoporosis	0.000516	0.00172	CcSEcCtD
Amiloride—Pruritus—Estropipate—osteoporosis	0.000515	0.00171	CcSEcCtD
Amiloride—Asthenia—Alendronate—osteoporosis	0.000514	0.00171	CcSEcCtD
Amiloride—Cough—Conjugated Estrogens—osteoporosis	0.000514	0.00171	CcSEcCtD
Amiloride—Dyspnoea—Risedronate—osteoporosis	0.000512	0.00171	CcSEcCtD
Amiloride—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000509	0.00169	CcSEcCtD
Amiloride—Fatigue—Ethinyl Estradiol—osteoporosis	0.000508	0.00169	CcSEcCtD
Amiloride—SLC9A1—Disease—SOST—osteoporosis	0.000507	0.00198	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PKM—osteoporosis	0.000507	0.00198	CbGpPWpGaD
Amiloride—Pruritus—Alendronate—osteoporosis	0.000507	0.00169	CcSEcCtD
Amiloride—Dyspepsia—Risedronate—osteoporosis	0.000506	0.00168	CcSEcCtD
Amiloride—Tinnitus—Estradiol—osteoporosis	0.000505	0.00168	CcSEcCtD
Amiloride—Constipation—Ethinyl Estradiol—osteoporosis	0.000504	0.00168	CcSEcCtD
Amiloride—Confusional state—Zoledronate—osteoporosis	0.000503	0.00168	CcSEcCtD
Amiloride—Arthralgia—Conjugated Estrogens—osteoporosis	0.000501	0.00167	CcSEcCtD
Amiloride—Chest pain—Conjugated Estrogens—osteoporosis	0.000501	0.00167	CcSEcCtD
Amiloride—Asthenia—Ibandronate—osteoporosis	0.0005	0.00167	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway—MYC—osteoporosis	0.000499	0.00194	CbGpPWpGaD
Amiloride—Nausea—Etidronic acid—osteoporosis	0.000499	0.00166	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000498	0.00166	CcSEcCtD
Amiloride—Diarrhoea—Estropipate—osteoporosis	0.000498	0.00166	CcSEcCtD
Amiloride—Gastrointestinal disorder—Risedronate—osteoporosis	0.000496	0.00165	CcSEcCtD
Amiloride—Fatigue—Risedronate—osteoporosis	0.000496	0.00165	CcSEcCtD
Amiloride—Insomnia—Pamidronate—osteoporosis	0.000494	0.00165	CcSEcCtD
Amiloride—Pruritus—Ibandronate—osteoporosis	0.000493	0.00164	CcSEcCtD
Amiloride—Pain—Risedronate—osteoporosis	0.000492	0.00164	CcSEcCtD
Amiloride—Constipation—Risedronate—osteoporosis	0.000492	0.00164	CcSEcCtD
Amiloride—Shock—Zoledronate—osteoporosis	0.000491	0.00164	CcSEcCtD
Amiloride—Paraesthesia—Pamidronate—osteoporosis	0.000491	0.00163	CcSEcCtD
Amiloride—Diarrhoea—Alendronate—osteoporosis	0.00049	0.00163	CcSEcCtD
Amiloride—Asthenia—Calcitriol—osteoporosis	0.00049	0.00163	CcSEcCtD
Amiloride—Dyspnoea—Pamidronate—osteoporosis	0.000487	0.00162	CcSEcCtD
Amiloride—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000486	0.00162	CcSEcCtD
Amiloride—Somnolence—Pamidronate—osteoporosis	0.000486	0.00162	CcSEcCtD
Amiloride—Pruritus—Calcitriol—osteoporosis	0.000483	0.00161	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—MYC—osteoporosis	0.000482	0.00188	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000482	0.00161	CcSEcCtD
Amiloride—Diarrhoea—Raloxifene—osteoporosis	0.000482	0.00161	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—TGFB1—osteoporosis	0.000481	0.00187	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PGLS—osteoporosis	0.000481	0.00187	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ANTXR2—osteoporosis	0.000481	0.00187	CbGpPWpGaD
Amiloride—Dyspepsia—Pamidronate—osteoporosis	0.000481	0.0016	CcSEcCtD
Amiloride—Dizziness—Estropipate—osteoporosis	0.000481	0.0016	CcSEcCtD
Amiloride—Alopecia—Estradiol—osteoporosis	0.000478	0.00159	CcSEcCtD
Amiloride—Diarrhoea—Ibandronate—osteoporosis	0.000477	0.00159	CcSEcCtD
Amiloride—Anorexia—Zoledronate—osteoporosis	0.000476	0.00158	CcSEcCtD
Amiloride—Decreased appetite—Pamidronate—osteoporosis	0.000475	0.00158	CcSEcCtD
Amiloride—Dizziness—Alendronate—osteoporosis	0.000474	0.00158	CcSEcCtD
Amiloride—Shock—Conjugated Estrogens—osteoporosis	0.000473	0.00157	CcSEcCtD
Amiloride—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000472	0.00157	CcSEcCtD
Amiloride—Fatigue—Pamidronate—osteoporosis	0.000471	0.00157	CcSEcCtD
Amiloride—Gastrointestinal pain—Risedronate—osteoporosis	0.00047	0.00157	CcSEcCtD
Amiloride—Constipation—Pamidronate—osteoporosis	0.000467	0.00156	CcSEcCtD
Amiloride—Pain—Pamidronate—osteoporosis	0.000467	0.00156	CcSEcCtD
Amiloride—Diarrhoea—Calcitriol—osteoporosis	0.000467	0.00156	CcSEcCtD
Amiloride—PLAU—E2F transcription factor network—MYC—osteoporosis	0.000466	0.00182	CbGpPWpGaD
Amiloride—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000466	0.00155	CcSEcCtD
Amiloride—Dizziness—Raloxifene—osteoporosis	0.000466	0.00155	CcSEcCtD
Amiloride—Flatulence—Estradiol—osteoporosis	0.000464	0.00155	CcSEcCtD
Amiloride—Tension—Estradiol—osteoporosis	0.000462	0.00154	CcSEcCtD
Amiloride—Vomiting—Estropipate—osteoporosis	0.000462	0.00154	CcSEcCtD
Amiloride—Dizziness—Ibandronate—osteoporosis	0.000461	0.00154	CcSEcCtD
Amiloride—Rash—Estropipate—osteoporosis	0.000459	0.00153	CcSEcCtD
Amiloride—Dermatitis—Estropipate—osteoporosis	0.000458	0.00153	CcSEcCtD
Amiloride—Anorexia—Conjugated Estrogens—osteoporosis	0.000458	0.00153	CcSEcCtD
Amiloride—Nervousness—Estradiol—osteoporosis	0.000458	0.00152	CcSEcCtD
Amiloride—Back pain—Estradiol—osteoporosis	0.000456	0.00152	CcSEcCtD
Amiloride—Headache—Estropipate—osteoporosis	0.000456	0.00152	CcSEcCtD
Amiloride—Vomiting—Alendronate—osteoporosis	0.000455	0.00152	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000455	0.00151	CcSEcCtD
Amiloride—Abdominal pain—Risedronate—osteoporosis	0.000454	0.00151	CcSEcCtD
Amiloride—Muscle spasms—Estradiol—osteoporosis	0.000453	0.00151	CcSEcCtD
Amiloride—Rash—Alendronate—osteoporosis	0.000452	0.0015	CcSEcCtD
Amiloride—Insomnia—Zoledronate—osteoporosis	0.000451	0.0015	CcSEcCtD
Amiloride—Dermatitis—Alendronate—osteoporosis	0.000451	0.0015	CcSEcCtD
Amiloride—Feeling abnormal—Pamidronate—osteoporosis	0.00045	0.0015	CcSEcCtD
Amiloride—Headache—Alendronate—osteoporosis	0.000449	0.00149	CcSEcCtD
Amiloride—Paraesthesia—Zoledronate—osteoporosis	0.000448	0.00149	CcSEcCtD
Amiloride—Vomiting—Raloxifene—osteoporosis	0.000448	0.00149	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000448	0.00174	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL1B—osteoporosis	0.000448	0.00174	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Pamidronate—osteoporosis	0.000447	0.00149	CcSEcCtD
Amiloride—Dyspnoea—Zoledronate—osteoporosis	0.000445	0.00148	CcSEcCtD
Amiloride—Rash—Raloxifene—osteoporosis	0.000444	0.00148	CcSEcCtD
Amiloride—Dermatitis—Raloxifene—osteoporosis	0.000444	0.00148	CcSEcCtD
Amiloride—Somnolence—Zoledronate—osteoporosis	0.000444	0.00148	CcSEcCtD
Amiloride—Vomiting—Ibandronate—osteoporosis	0.000443	0.00148	CcSEcCtD
Amiloride—Tremor—Estradiol—osteoporosis	0.000442	0.00147	CcSEcCtD
Amiloride—PLAU—Hemostasis—RAP1A—osteoporosis	0.000441	0.00172	CbGpPWpGaD
Amiloride—Headache—Raloxifene—osteoporosis	0.000441	0.00147	CcSEcCtD
Amiloride—Rash—Ibandronate—osteoporosis	0.00044	0.00146	CcSEcCtD
Amiloride—Dermatitis—Ibandronate—osteoporosis	0.000439	0.00146	CcSEcCtD
Amiloride—Dyspepsia—Zoledronate—osteoporosis	0.000439	0.00146	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000438	0.00146	CcSEcCtD
Amiloride—Headache—Ibandronate—osteoporosis	0.000437	0.00145	CcSEcCtD
Amiloride—Insomnia—Conjugated Estrogens—osteoporosis	0.000435	0.00145	CcSEcCtD
Amiloride—Vomiting—Calcitriol—osteoporosis	0.000434	0.00145	CcSEcCtD
Amiloride—Decreased appetite—Zoledronate—osteoporosis	0.000434	0.00144	CcSEcCtD
Amiloride—Nausea—Estropipate—osteoporosis	0.000432	0.00144	CcSEcCtD
Amiloride—Abdominal pain—Pamidronate—osteoporosis	0.000432	0.00144	CcSEcCtD
Amiloride—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000432	0.00144	CcSEcCtD
Amiloride—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000431	0.00143	CcSEcCtD
Amiloride—Rash—Calcitriol—osteoporosis	0.00043	0.00143	CcSEcCtD
Amiloride—Fatigue—Zoledronate—osteoporosis	0.00043	0.00143	CcSEcCtD
Amiloride—Dermatitis—Calcitriol—osteoporosis	0.00043	0.00143	CcSEcCtD
Amiloride—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000428	0.00143	CcSEcCtD
Amiloride—Headache—Calcitriol—osteoporosis	0.000428	0.00142	CcSEcCtD
Amiloride—Somnolence—Conjugated Estrogens—osteoporosis	0.000427	0.00142	CcSEcCtD
Amiloride—Pain—Zoledronate—osteoporosis	0.000427	0.00142	CcSEcCtD
Amiloride—Constipation—Zoledronate—osteoporosis	0.000427	0.00142	CcSEcCtD
Amiloride—Nausea—Alendronate—osteoporosis	0.000425	0.00142	CcSEcCtD
Amiloride—SLC9A1—Metabolism—PKM—osteoporosis	0.000425	0.00165	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—FDPS—osteoporosis	0.000425	0.00165	CbGpPWpGaD
Amiloride—Vertigo—Estradiol—osteoporosis	0.000423	0.00141	CcSEcCtD
Amiloride—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000423	0.00141	CcSEcCtD
Amiloride—Asthenia—Ethinyl Estradiol—osteoporosis	0.000423	0.00141	CcSEcCtD
Amiloride—Nausea—Raloxifene—osteoporosis	0.000418	0.00139	CcSEcCtD
Amiloride—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000418	0.00139	CcSEcCtD
Amiloride—Pruritus—Ethinyl Estradiol—osteoporosis	0.000417	0.00139	CcSEcCtD
Amiloride—Palpitations—Estradiol—osteoporosis	0.000416	0.00139	CcSEcCtD
Amiloride—PLAU—ATF-2 transcription factor network—IL6—osteoporosis	0.000416	0.00162	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000415	0.00138	CcSEcCtD
Amiloride—Fatigue—Conjugated Estrogens—osteoporosis	0.000414	0.00138	CcSEcCtD
Amiloride—Nausea—Ibandronate—osteoporosis	0.000414	0.00138	CcSEcCtD
Amiloride—Asthenia—Risedronate—osteoporosis	0.000412	0.00137	CcSEcCtD
Amiloride—Feeling abnormal—Zoledronate—osteoporosis	0.000411	0.00137	CcSEcCtD
Amiloride—Cough—Estradiol—osteoporosis	0.000411	0.00137	CcSEcCtD
Amiloride—Constipation—Conjugated Estrogens—osteoporosis	0.000411	0.00137	CcSEcCtD
Amiloride—Pain—Conjugated Estrogens—osteoporosis	0.000411	0.00137	CcSEcCtD
Amiloride—SLC9A1—Disease—GSN—osteoporosis	0.000409	0.00159	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Zoledronate—osteoporosis	0.000408	0.00136	CcSEcCtD
Amiloride—Pruritus—Risedronate—osteoporosis	0.000407	0.00135	CcSEcCtD
Amiloride—Nausea—Calcitriol—osteoporosis	0.000406	0.00135	CcSEcCtD
Amiloride—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000403	0.00134	CcSEcCtD
Amiloride—SLC9A1—Metabolism—PGLS—osteoporosis	0.000403	0.00157	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GPD2—osteoporosis	0.000403	0.00157	CbGpPWpGaD
Amiloride—Arthralgia—Estradiol—osteoporosis	0.000401	0.00134	CcSEcCtD
Amiloride—Chest pain—Estradiol—osteoporosis	0.000401	0.00134	CcSEcCtD
Amiloride—PLAU—Hemostasis—FGA—osteoporosis	0.0004	0.00156	CbGpPWpGaD
Amiloride—Abdominal pain—Zoledronate—osteoporosis	0.000395	0.00131	CcSEcCtD
Amiloride—Diarrhoea—Risedronate—osteoporosis	0.000393	0.00131	CcSEcCtD
Amiloride—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000393	0.00131	CcSEcCtD
Amiloride—Asthenia—Pamidronate—osteoporosis	0.000392	0.00131	CcSEcCtD
Amiloride—Dizziness—Ethinyl Estradiol—osteoporosis	0.00039	0.0013	CcSEcCtD
Amiloride—Confusional state—Estradiol—osteoporosis	0.000388	0.00129	CcSEcCtD
Amiloride—Pruritus—Pamidronate—osteoporosis	0.000387	0.00129	CcSEcCtD
Amiloride—Dizziness—Risedronate—osteoporosis	0.00038	0.00127	CcSEcCtD
Amiloride—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00038	0.00127	CcSEcCtD
Amiloride—Shock—Estradiol—osteoporosis	0.000378	0.00126	CcSEcCtD
Amiloride—Vomiting—Ethinyl Estradiol—osteoporosis	0.000375	0.00125	CcSEcCtD
Amiloride—Diarrhoea—Pamidronate—osteoporosis	0.000374	0.00124	CcSEcCtD
Amiloride—Rash—Ethinyl Estradiol—osteoporosis	0.000372	0.00124	CcSEcCtD
Amiloride—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000371	0.00124	CcSEcCtD
Amiloride—Headache—Ethinyl Estradiol—osteoporosis	0.000369	0.00123	CcSEcCtD
Amiloride—SLC9A1—Metabolism—ATIC—osteoporosis	0.000368	0.00143	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PNP—osteoporosis	0.000368	0.00143	CbGpPWpGaD
Amiloride—Vomiting—Risedronate—osteoporosis	0.000365	0.00122	CcSEcCtD
Amiloride—PLAU—Hemostasis—FGB—osteoporosis	0.000364	0.00142	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IL6—osteoporosis	0.000362	0.00141	CbGpPWpGaD
Amiloride—Rash—Risedronate—osteoporosis	0.000362	0.00121	CcSEcCtD
Amiloride—Dermatitis—Risedronate—osteoporosis	0.000362	0.00121	CcSEcCtD
Amiloride—Dizziness—Pamidronate—osteoporosis	0.000361	0.0012	CcSEcCtD
Amiloride—Headache—Risedronate—osteoporosis	0.00036	0.0012	CcSEcCtD
Amiloride—Asthenia—Zoledronate—osteoporosis	0.000358	0.00119	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—MYC—osteoporosis	0.000357	0.00139	CbGpPWpGaD
Amiloride—SLC9A1—Disease—LRP5—osteoporosis	0.000356	0.00139	CbGpPWpGaD
Amiloride—Pruritus—Zoledronate—osteoporosis	0.000353	0.00118	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00035	0.00117	CcSEcCtD
Amiloride—Nausea—Ethinyl Estradiol—osteoporosis	0.00035	0.00117	CcSEcCtD
Amiloride—Insomnia—Estradiol—osteoporosis	0.000348	0.00116	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TGFB1—osteoporosis	0.000348	0.00135	CbGpPWpGaD
Amiloride—Vomiting—Pamidronate—osteoporosis	0.000347	0.00116	CcSEcCtD
Amiloride—Paraesthesia—Estradiol—osteoporosis	0.000345	0.00115	CcSEcCtD
Amiloride—Asthenia—Conjugated Estrogens—osteoporosis	0.000345	0.00115	CcSEcCtD
Amiloride—Rash—Pamidronate—osteoporosis	0.000345	0.00115	CcSEcCtD
Amiloride—Dermatitis—Pamidronate—osteoporosis	0.000344	0.00115	CcSEcCtD
Amiloride—Dyspnoea—Estradiol—osteoporosis	0.000343	0.00114	CcSEcCtD
Amiloride—Headache—Pamidronate—osteoporosis	0.000342	0.00114	CcSEcCtD
Amiloride—Somnolence—Estradiol—osteoporosis	0.000342	0.00114	CcSEcCtD
Amiloride—Diarrhoea—Zoledronate—osteoporosis	0.000341	0.00114	CcSEcCtD
Amiloride—Nausea—Risedronate—osteoporosis	0.000341	0.00114	CcSEcCtD
Amiloride—SLC9A1—Disease—LRP6—osteoporosis	0.00034	0.00132	CbGpPWpGaD
Amiloride—Pruritus—Conjugated Estrogens—osteoporosis	0.00034	0.00113	CcSEcCtD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000339	0.00132	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000339	0.00132	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000339	0.00132	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000339	0.00132	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000339	0.00132	CbGpPWpGaD
Amiloride—Dyspepsia—Estradiol—osteoporosis	0.000339	0.00113	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—MYC—osteoporosis	0.000338	0.00132	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TGFB1—osteoporosis	0.000338	0.00131	CbGpPWpGaD
Amiloride—Decreased appetite—Estradiol—osteoporosis	0.000334	0.00111	CcSEcCtD
Amiloride—Gastrointestinal disorder—Estradiol—osteoporosis	0.000332	0.00111	CcSEcCtD
Amiloride—Fatigue—Estradiol—osteoporosis	0.000332	0.0011	CcSEcCtD
Amiloride—Dizziness—Zoledronate—osteoporosis	0.00033	0.0011	CcSEcCtD
Amiloride—Constipation—Estradiol—osteoporosis	0.000329	0.0011	CcSEcCtD
Amiloride—Pain—Estradiol—osteoporosis	0.000329	0.0011	CcSEcCtD
Amiloride—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000329	0.00109	CcSEcCtD
Amiloride—SLC9A1—Disease—LTF—osteoporosis	0.000327	0.00127	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RPL24—osteoporosis	0.000327	0.00127	CbGpPWpGaD
Amiloride—Nausea—Pamidronate—osteoporosis	0.000325	0.00108	CcSEcCtD
Amiloride—Dizziness—Conjugated Estrogens—osteoporosis	0.000318	0.00106	CcSEcCtD
Amiloride—Vomiting—Zoledronate—osteoporosis	0.000317	0.00106	CcSEcCtD
Amiloride—Feeling abnormal—Estradiol—osteoporosis	0.000317	0.00106	CcSEcCtD
Amiloride—Rash—Zoledronate—osteoporosis	0.000315	0.00105	CcSEcCtD
Amiloride—Gastrointestinal pain—Estradiol—osteoporosis	0.000315	0.00105	CcSEcCtD
Amiloride—Dermatitis—Zoledronate—osteoporosis	0.000314	0.00105	CcSEcCtD
Amiloride—SLC9A1—Metabolism—OXCT1—osteoporosis	0.000313	0.00122	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CA2—osteoporosis	0.000313	0.00122	CbGpPWpGaD
Amiloride—Headache—Zoledronate—osteoporosis	0.000313	0.00104	CcSEcCtD
Amiloride—Vomiting—Conjugated Estrogens—osteoporosis	0.000306	0.00102	CcSEcCtD
Amiloride—SLC9A1—Metabolism—MGLL—osteoporosis	0.000305	0.00119	CbGpPWpGaD
Amiloride—Abdominal pain—Estradiol—osteoporosis	0.000304	0.00101	CcSEcCtD
Amiloride—Rash—Conjugated Estrogens—osteoporosis	0.000303	0.00101	CcSEcCtD
Amiloride—Dermatitis—Conjugated Estrogens—osteoporosis	0.000303	0.00101	CcSEcCtD
Amiloride—Headache—Conjugated Estrogens—osteoporosis	0.000301	0.001	CcSEcCtD
Amiloride—Nausea—Zoledronate—osteoporosis	0.000296	0.000987	CcSEcCtD
Amiloride—Nausea—Conjugated Estrogens—osteoporosis	0.000285	0.000951	CcSEcCtD
Amiloride—SLC9A1—Disease—ACP5—osteoporosis	0.000283	0.0011	CbGpPWpGaD
Amiloride—Asthenia—Estradiol—osteoporosis	0.000276	0.000919	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000273	0.00106	CbGpPWpGaD
Amiloride—Pruritus—Estradiol—osteoporosis	0.000272	0.000906	CcSEcCtD
Amiloride—SLC9A1—Disease—TPI1—osteoporosis	0.000264	0.00103	CbGpPWpGaD
Amiloride—Diarrhoea—Estradiol—osteoporosis	0.000263	0.000876	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL6—osteoporosis	0.000262	0.00102	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—IDH2—osteoporosis	0.00026	0.00101	CbGpPWpGaD
Amiloride—Dizziness—Estradiol—osteoporosis	0.000254	0.000847	CcSEcCtD
Amiloride—SLC9A1—Disease—P4HB—osteoporosis	0.000248	0.000965	CbGpPWpGaD
Amiloride—Vomiting—Estradiol—osteoporosis	0.000245	0.000814	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CYP27A1—osteoporosis	0.000244	0.00095	CbGpPWpGaD
Amiloride—SLC9A1—Disease—GAPDH—osteoporosis	0.000243	0.000947	CbGpPWpGaD
Amiloride—Rash—Estradiol—osteoporosis	0.000243	0.000808	CcSEcCtD
Amiloride—Dermatitis—Estradiol—osteoporosis	0.000242	0.000807	CcSEcCtD
Amiloride—Headache—Estradiol—osteoporosis	0.000241	0.000802	CcSEcCtD
Amiloride—SLC9A1—Metabolism—ACP5—osteoporosis	0.000237	0.000924	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NFATC1—osteoporosis	0.000231	0.0009	CbGpPWpGaD
Amiloride—SLC9A1—Disease—DKK1—osteoporosis	0.000229	0.000893	CbGpPWpGaD
Amiloride—Nausea—Estradiol—osteoporosis	0.000228	0.000761	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000224	0.000871	CbGpPWpGaD
Amiloride—SLC9A1—Disease—WNT1—osteoporosis	0.000221	0.00086	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—TPI1—osteoporosis	0.000221	0.000859	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGA—osteoporosis	0.000215	0.000836	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—P4HB—osteoporosis	0.000208	0.000808	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GAPDH—osteoporosis	0.000204	0.000793	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—RAP1A—osteoporosis	0.000198	0.000772	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ENO1—osteoporosis	0.000191	0.000746	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PSMA2—osteoporosis	0.000189	0.000735	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PSMA5—osteoporosis	0.000189	0.000735	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CALCA—osteoporosis	0.000176	0.000685	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IGF1—osteoporosis	0.000165	0.000642	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ENO1—osteoporosis	0.00016	0.000624	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KL—osteoporosis	0.00016	0.000622	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PSMA5—osteoporosis	0.000158	0.000615	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PSMA2—osteoporosis	0.000158	0.000615	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000129	0.000502	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP19A1—osteoporosis	0.000128	0.000499	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ADCY5—osteoporosis	0.000125	0.000487	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.00012	0.000468	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000118	0.000457	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MTHFR—osteoporosis	0.000115	0.000448	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.00011	0.000426	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IRS2—osteoporosis	0.000109	0.000426	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ADCY5—osteoporosis	0.000105	0.000408	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GPX1—osteoporosis	0.000104	0.000406	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000102	0.000398	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TGFB1—osteoporosis	9.88e-05	0.000385	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—MTHFR—osteoporosis	9.63e-05	0.000375	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IRS1—osteoporosis	9.55e-05	0.000372	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FDPS—osteoporosis	9.2e-05	0.000358	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PKM—osteoporosis	9.2e-05	0.000358	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—ADCY5—osteoporosis	9e-05	0.000351	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6R—osteoporosis	8.97e-05	0.000349	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPD2—osteoporosis	8.72e-05	0.000339	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PGLS—osteoporosis	8.72e-05	0.000339	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PKM—osteoporosis	8.57e-05	0.000334	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FDPS—osteoporosis	8.57e-05	0.000334	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—ADCY5—osteoporosis	8.39e-05	0.000327	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PGLS—osteoporosis	8.13e-05	0.000316	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPD2—osteoporosis	8.13e-05	0.000316	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PNP—osteoporosis	7.97e-05	0.00031	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ATIC—osteoporosis	7.97e-05	0.00031	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—POMC—osteoporosis	7.7e-05	0.0003	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ATIC—osteoporosis	7.43e-05	0.000289	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PNP—osteoporosis	7.43e-05	0.000289	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—OXCT1—osteoporosis	6.78e-05	0.000264	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CA2—osteoporosis	6.78e-05	0.000264	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MGLL—osteoporosis	6.61e-05	0.000257	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—OXCT1—osteoporosis	6.32e-05	0.000246	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CA2—osteoporosis	6.32e-05	0.000246	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MGLL—osteoporosis	6.16e-05	0.00024	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—IDH2—osteoporosis	5.62e-05	0.000219	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MYC—osteoporosis	5.32e-05	0.000207	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TGFB1—osteoporosis	5.31e-05	0.000207	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP27A1—osteoporosis	5.28e-05	0.000206	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—IDH2—osteoporosis	5.24e-05	0.000204	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ACP5—osteoporosis	5.14e-05	0.0002	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP27A1—osteoporosis	4.92e-05	0.000192	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.84e-05	0.000188	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ACP5—osteoporosis	4.79e-05	0.000186	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TPI1—osteoporosis	4.78e-05	0.000186	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.51e-05	0.000176	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—P4HB—osteoporosis	4.49e-05	0.000175	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TPI1—osteoporosis	4.45e-05	0.000173	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GAPDH—osteoporosis	4.41e-05	0.000172	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—RAP1A—osteoporosis	4.29e-05	0.000167	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—P4HB—osteoporosis	4.19e-05	0.000163	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GAPDH—osteoporosis	4.11e-05	0.00016	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—RAP1A—osteoporosis	4e-05	0.000156	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—osteoporosis	4e-05	0.000156	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ENO1—osteoporosis	3.47e-05	0.000135	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PSMA2—osteoporosis	3.42e-05	0.000133	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PSMA5—osteoporosis	3.42e-05	0.000133	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ENO1—osteoporosis	3.24e-05	0.000126	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PSMA2—osteoporosis	3.19e-05	0.000124	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PSMA5—osteoporosis	3.19e-05	0.000124	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP19A1—osteoporosis	2.77e-05	0.000108	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP19A1—osteoporosis	2.59e-05	0.000101	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ADCY5—osteoporosis	2.27e-05	8.83e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPX1—osteoporosis	2.26e-05	8.8e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ADCY5—osteoporosis	2.11e-05	8.23e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPX1—osteoporosis	2.11e-05	8.2e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTHFR—osteoporosis	2.09e-05	8.12e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTHFR—osteoporosis	1.94e-05	7.57e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—POMC—osteoporosis	1.67e-05	6.49e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—POMC—osteoporosis	1.55e-05	6.05e-05	CbGpPWpGaD
